Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Study Efficacy of Enhancing Cognitive Reserve in Patients With a First Bipolar Episode

NCT06081634
unknownnot_applicable

Enhancing Cognitive Reserve of the Offsprings of Bipolar and Schizophrenic Patients

NCT03722082
unknownnot_applicable

Treating Early Stages With an Intervention Targeting Cognitive Reserve

NCT05288049

Clinical Trials (3)

Showing 3 of 3 trials
NCT06081634Not Applicable

Study Efficacy of Enhancing Cognitive Reserve in Patients With a First Bipolar Episode

Completed
NCT03722082Not Applicable

Enhancing Cognitive Reserve of the Offsprings of Bipolar and Schizophrenic Patients

Unknown
NCT05288049Not Applicable

Treating Early Stages With an Intervention Targeting Cognitive Reserve

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3